Literature DB >> 31807549

Inhibition of human cervical cancer cell invasion by IL-37 involving runt related transcription factor 2 suppression.

Ping Ouyang1, Kun Wu1,2, Liudan Su1,2, Weifang An2, Yanhong Bie2, He Zhang3, Haixian Kang2, Enping Jiang1, Wei Zhu1, Yunhong Yao1, Xinrong Hu1, Zhangquan Chen1, Sen Wang1,2.   

Abstract

BACKGROUND: IL-37 is a newly anti-inflammatory cytokine whose function is largely unknown in cancer. Our preliminary experiment found IL-37 could inhibit the invasion of human cervical cancer (CC) cells and influence the expression of RUNX family whose function was also unclear in CC. The present study aims to further investigate the effects of IL-37 on cell invasion and runt related transcription factor 2 (RUNX2) expression in CC cell lines.
METHODS: Firstly, plasmid overexpressing IL-37 or RUNX2 was transfected into Siha and C33A cells by Hilymax. Then, the effects of IL-37 on the mRNA expression of RUNX1, RUNX2 and RUNX3 gene were detected by quantitative real-time polymerase chain reaction. Protein expression was measured by Western blot and the grayscale scanning analysis. Finally, the effects of IL-37 or RUNX2 on cell invasion were tested by transwell assay.
RESULTS: IL-37 inhibited the mRNA expression of RUNX1 and RUNX2, and increased that of RUNX3 in CC cells. Among the three RUNX genes, RUNX2 showed the most significant change in mRNA expression (decreased by78.5% in Siha cells and by 61.5% in C33A cells) and thus was chosen for the following study. Overexpressed IL-37 inhibited cell invasion by 36.23% in Siha cells (P<0.05) and 26.21% in C33A cells (P<0.01). Overexpression of RUNX2 promoted cell invasion. Up-regulation of IL-37 suppressed markedly the mRNA and protein expression of RUNX2. Furthermore, overexpressed RUNX2 partially restored the inhibited cell invasion by IL-37 to 86.62% in Siha cells (P<0.01) and 87.08% in C33A cells (P<0.01).
CONCLUSIONS: IL-37 can significantly inhibit the cell invasion of Siha and C33A cells, which involves the suppression of RUNX2. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  IL-37; cell invasion; cervical cancer (CC); cytokine; runt related transcription factor 2 (RUNX2); tumor

Year:  2019        PMID: 31807549      PMCID: PMC6861783          DOI: 10.21037/atm.2019.09.38

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  41 in total

1.  Mast cell and cancer with special emphasis on il-37 an anti-inflammatory and inhibitor of innate immunity: new frontiers.

Authors:  F Carinci; G Lessiani; E Spinas; S K Kritas; G Ronconi; Al Caraffa; P Conti
Journal:  J Biol Regul Homeost Agents       Date:  2016 Oct-Dec       Impact factor: 1.711

2.  O-GlcNAc modification of the runt-related transcription factor 2 (Runx2) links osteogenesis and nutrient metabolism in bone marrow mesenchymal stem cells.

Authors:  Alexis K Nagel; Lauren E Ball
Journal:  Mol Cell Proteomics       Date:  2014-09-03       Impact factor: 5.911

Review 3.  The role of IL-37 in cancer.

Authors:  Vivi A Ding; Ziwen Zhu; Huaping Xiao; Mark R Wakefield; Qian Bai; Yujiang Fang
Journal:  Med Oncol       Date:  2016-06-01       Impact factor: 3.064

Review 4.  IL-37: a new anti-inflammatory cytokine of the IL-1 family.

Authors:  Diana Boraschi; Davide Lucchesi; Stefan Hainzl; Maria Leitner; Elisabeth Maier; Doris Mangelberger; Gertie J Oostingh; Tobias Pfaller; Claudia Pixner; Gernot Posselt; Paola Italiani; Marcel F Nold; Claudia A Nold-Petry; Philip Bufler; Charles A Dinarello
Journal:  Eur Cytokine Netw       Date:  2011-09       Impact factor: 3.450

5.  The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma.

Authors:  Rajeev K Boregowda; Daniel J Medina; Elke Markert; Michael A Bryan; Wenjin Chen; Suzie Chen; Anna Rabkin; Michael J Vido; Samuel I Gunderson; Marina Chekmareva; David J Foran; Ahmed Lasfar; James S Goydos; Karine A Cohen-Solal
Journal:  Oncotarget       Date:  2016-05-17

6.  Osteogenic Programming of Human Mesenchymal Stem Cells with Highly Efficient Intracellular Delivery of RUNX2.

Authors:  Lalitha Thiagarajan; Hosam Al-Deen M Abu-Awwad; James E Dixon
Journal:  Stem Cells Transl Med       Date:  2017-10-31       Impact factor: 6.940

7.  MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2.

Authors:  Yuanlong Xie; Wenchao Sun; Zhouming Deng; Xiaobin Zhu; Chao Hu; Lin Cai
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379

8.  Integrated genomic and molecular characterization of cervical cancer.

Authors: 
Journal:  Nature       Date:  2017-01-23       Impact factor: 49.962

9.  IL-37 promotes cell apoptosis in cervical cancer involving Bim upregulation.

Authors:  Ping Ouyang; Weifang An; Renhuai Chen; He Zhang; Danrui Chen; Enping Jiang; Wei Zhu; Peng Li; Hongsheng Guo; Zhangquan Chen; Sen Wang
Journal:  Onco Targets Ther       Date:  2019-04-10       Impact factor: 4.147

10.  MicroRNA-217 inhibits cell proliferation and invasion by targeting Runx2 in human glioma.

Authors:  Yonggang Zhu; Hongguang Zhao; Li Feng; Songbai Xu
Journal:  Am J Transl Res       Date:  2016-03-15       Impact factor: 4.060

View more
  4 in total

1.  CDK6 increases glycolysis and suppresses autophagy by mTORC1-HK2 pathway activation in cervical cancer cells.

Authors:  Xiaoxi Zhang; Yunxia Sun; Siyao Cheng; Yanjing Yao; Xintao Hua; Yueyue Shi; Xiaoqin Jin; Jieli Pan; Miaofen G Hu; Pian Ying; Xiaoli Hou; Daozong Xia
Journal:  Cell Cycle       Date:  2022-02-15       Impact factor: 5.173

2.  The microRNA-130a-5p/RUNX2/STK32A network modulates tumor invasive and metastatic potential in non-small cell lung cancer.

Authors:  Fang Ma; Yangchun Xie; Yiyu Lei; Zengshuyu Kuang; Xianling Liu
Journal:  BMC Cancer       Date:  2020-06-22       Impact factor: 4.430

3.  miR-218-5p/RUNX2 Axis Positively Regulates Proliferation and Is Associated with Poor Prognosis in Cervical Cancer.

Authors:  Merlin Itsel Cruz-De la Rosa; Hilda Jiménez-Wences; Judit Alarcón-Millán; Manuel Joaquín Romero-López; Carlos Alberto Castañón-Sánchez; Eric Genaro Salmerón-Bárcenas; Gloria Fernández-Tilapa
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

Review 4.  Current Understanding of IL-37 in Human Health and Disease.

Authors:  Zhangci Su; Xiaoan Tao
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.